Martha Sajatovic, MD

Long-Acting Injectables for Bipolar Disorder

Publish date: April 17, 2023

Dr Martha Sajatovic, of the University Hospitals of Cleveland, discusses short- and long-term effects of bipolar disorder and the potential of...

Author:: Lori Harper, PhD; Bonnie M. Dobbs, PhD; Shana D. Stites, PsyD, MS, MA; Martha Sajatovic, MD; Kathleen C. Buckwalter, PhD, RN, FAAN; Sandy C. Burgener, PhD, RN, FAAN

There’s much you can do to address stigmatizing attitudes, beliefs, and behaviors.

Author:: Helen C. Kales, MD; Benoit H. Mulsant, MD, MS; Martha Sajatovic, MD

When to use SGAs for behavioral and psychological symptoms of dementia. Third of 3 parts.

Author:: Benoit H. Mulsant, MD, MS; Helen C. Kales, MD; Martha Sajatovic, MD

New evidence supports augmenting an antidepressant with a low-dose antipsychotic in older adults.

Author:: Martha Sajatovic, MD; Helen C. Kales, MD; Benoit H. Mulsant, MD, MS

Antipsychotics are FDA-approved as a primary treatment for schizophrenia and bipolar disorder and as adjunctive therapy for major depressive...

Author:: Corinna Falck-Ytter, MD; Stephanie W. Kanuch, MEd; Richard McCormick, PhD; Michael Purdum, PhD; Neal V. Dawson, MD; Shari D. Bolen, MD, MPH; Martha Sajatovic, MD

Rethinking A1C targets for patients with mental illness? The article, “Diabetes update: Your guide to the latest ADA standards,” by Shubrook, et...